Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Constitutive IKK2 activation in acinar cells is sufficient to induce pancreatitis in vivo
Bernd Baumann, Martin Wagner, Tamara Aleksic, Götz von Wichert, Christoph K. Weber, Guido Adler, Thomas Wirth
Bernd Baumann, Martin Wagner, Tamara Aleksic, Götz von Wichert, Christoph K. Weber, Guido Adler, Thomas Wirth
View: Text | PDF
Research Article

Constitutive IKK2 activation in acinar cells is sufficient to induce pancreatitis in vivo

  • Text
  • PDF
Abstract

Activation of the inhibitor of NF-κB kinase/NF-κB (IKK/NF-κB) system and expression of proinflammatory mediators are major events in acute pancreatitis. However, the in vivo consequences of IKK activation on the onset and progression of acute pancreatitis remain unclear. Therefore, we modulated IKK activity conditionally in pancreatic acinar cells. Transgenic mice expressing the reverse tetracycline-responsive transactivator (rtTA) gene under the control of the rat elastase promoter were generated to mediate acinar cell–specific expression of IKK2 alleles. Expression of dominant-negative IKK2 ameliorated cerulein-induced pancreatitis but did not affect activation of trypsin, an initial event in experimental pancreatitis. Notably, expression of constitutively active IKK2 was sufficient to induce acute pancreatitis. This acinar cell–specific phenotype included edema, cellular infiltrates, necrosis, and elevation of serum lipase levels as well as pancreatic fibrosis. IKK2 activation caused increased expression of known NF-κB target genes, including mediators of the inflammatory response such as TNF-α and ICAM-1. Indeed, inhibition of TNF-α activity identified this cytokine as an important effector of IKK2-induced pancreatitis. Our data identify the IKK/NF-κB pathway in acinar cells as being key to the development of experimental pancreatitis and the major factor in the inflammatory response typical of this disease.

Authors

Bernd Baumann, Martin Wagner, Tamara Aleksic, Götz von Wichert, Christoph K. Weber, Guido Adler, Thomas Wirth

×

Figure 1

Mouse model for conditional regulation of IKK activity in pancreatic acinar cells.

Options: View larger image (or click on image) Download as PowerPoint
Mouse model for conditional regulation of IKK activity in pancreatic aci...
(A) Transgenic approach for Dox-regulated expression of IKK2-CA and IKK2-DN in the exocrine pancreas. The Ela promoter (Ela.P) controls the expression of rtTA. In the presence of Dox the rtTA protein binds to the bidirectional promoter (tetO)7 and activates the transcription (arrowheads) of luciferase and either IKK2-DN or IKK2-CA. rTetR, reverse tetracycline repressor; VP16, herpes simplex protein. (B) Luciferase activity was measured in pancreas (Pa), spleen (Sp), and lung (Lu) of double-transgenic Ela.rtTA×IKK2-DN mice without Dox or 24 hours after Dox application i.p. Results were expressed as relative light units (RLU) per μg protein. (C) In vivo imaging of luciferase activity in double-transgenic Ela.rtTA×IKK2-DN mice (Ela.DN 2×Tg) showing restricted luciferase expression to the pancreatic region 24 hours after Dox application. (D) IKK2-DN transgene expression was monitored by immunoblot in pancreatic extracts of Ela.rtTA×IKK2-DN mice 24 and 48 hours after Dox application or in uninduced Ela.rtTA×IKK2-DN controls. ERK2 served as loading control. (E) IKK2 kinase assay (KA) with isolated acini from Dox-treated Ela.rtTA×IKK2-DN mice and single-transgenic IKK2-DN control mice (DN 1×Tg) treated in vitro with cerulein (2 hours) showed decreased IKK activity in Ela.rtTA×IKK2-DN compared with single-transgenic IKK2-DN mice. GST, glutathione-S-transferase.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts